Evidence map›Paper›PMID 42388972›Full record

ArticleFrontiers in cell and developmental biology2026

Rare variants of

Kai Liao, Yijian Zhu, Yuwei Zhao, Yi Liu, Hongyan Chen, Daru Lu

Abstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kai Liao *State Key Laboratory of Genetics and Development of Complex Phenotypes and MOE Engineering Research Center of Gene Technology, School of Life Sciences and Taizhou Institute of Health Science, Fudan University, Shanghai, China.
Yijian Zhu *NHC Key Laboratory of Birth Defects and Reproductive Health, Chongqing Population and Family Planning Science and Technology Research Institute, Chongqing, China.
Yuwei ZhaoState Key Laboratory of Genetics and Development of Complex Phenotypes and MOE Engineering Research Center of Gene Technology, School of Life Sciences and Taizhou Institute of Health Science, Fudan University, Shanghai, China.
Yi LiuDepartment of Gastroenterology, Huashan Hospital, Fudan University, Shanghai, China.
Hongyan ChenState Key Laboratory of Genetics and Development of Complex Phenotypes and MOE Engineering Research Center of Gene Technology, School of Life Sciences and Taizhou Institute of Health Science, Fudan University, Shanghai, China.
Daru LuState Key Laboratory of Genetics and Development of Complex Phenotypes and MOE Engineering Research Center of Gene Technology, School of Life Sciences and Taizhou Institute of Health Science, Fudan University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Recurrent spontaneous abortion (RSA) is associated with embryonic chromosomal abnormalities, yet the maternal genetic factors predisposing to the production of aneuploid gametes remain incompletely understood. Identifying germline variants that disrupt meiotic chromosome segregation may elucidate the genetic etiology of RSA. Methods: Peripheral blood DNA was collected from 100 RSA patients for whom aneuploidy of embryonic origin had been confirmed in prior miscarriage specimens, and whole-exome sequencing (WES) was performed. Rare missense variants in candidate meiotic genes were identified and prioritized for functional analysis. The effect of GPSM2 loss-of-function was modeled via siRNA-mediated knockdown in germ cell lines, and meiotic progression, ploidy outcomes, and spindle-associated protein localization were assessed in vitro and in vivo. Results: Two patients harbored rare heterozygous missense point mutations in GPSM2 (G protein signaling modulator 2). GPSM2 knockdown resulted in a marked increase in diploid spermatocytes (NC: 10.6% vs. GPSM2-siRNA: 53.8%) and a corresponding decrease in haploid spermatids (NC: 57.8% vs. GPSM2-siRNA: 5.49%), indicating failure of the first meiotic division, while earlier spermatogenic stages remained unaffected. Mechanistically, GPSM2 was found to interact with the nuclear mitotic apparatus (NUMA) protein; upon GPSM2 depletion, chromosome separation was arrested at metaphase in GC-2 cells, and NUMA failed to localize to the spindle poles. Discussion: These findings suggest that rare GPSM2 missense mutations predicted to impair gene function may compromise first meiotic chromosome segregation through disruption of the GPSM2-NUMA interaction at the spindle pole, thereby predisposing carriers to produce aneuploid germ cells. Fertilization of such aneuploid gametes would yield chromosomally abnormal embryos, providing a mechanistic basis for RSA in these patients. However, definitive causal attribution awaits direct functional characterization of the specific missense variants identified, as the current study employed siRNA-mediated knockdown as a surrogate loss-of-function model.

Indexed as

aneuploidyG protein signaling modulator 2nuclear mitotic apparatusrecurrent spontaneous abortionwhole-exome sequencing

Identifiers

PMID42388972
PMCPMC13318996

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.